Chinese guideline for lipid management(2023):a new guideline rich in domestic elements for controlling dyslipidemia

被引：0
作者：
Jian-Jun LI [1 ]
机构：
[1] Division of Cardio-Metabolic Center, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences, Peking Union Medical College
来源：
Journal of Geriatric Cardiology | 2023年 / 09期
关键词：
D O I：
暂无
中图分类号：
R589.2 [脂肪代谢障碍];
学科分类号：
1002 ; 100201 ;
摘要：
Atherosclerotic cardiovascular disease(ASCVD) is the leading cause of death among urban and rural residents in China,and elevated low-density lipoprotein cholesterol(LDL-C) is a causal risk factor for ASCVD.[1,2]Considering the increasing burden of ASCVD,
引用
收藏
页码：618 / 620
页数：3
相关论文
共 8 条
  • [1] Vulnerable atherosclerotic plaque features: findings from coronary imaging
    Osamu Kurihara
    Masamichi Takano
    Yasushi Miyauchi
    Kyoichi Mizuno
    Wataru Shimizu
    [J]. Journal of Geriatric Cardiology, 2021, 18 (07) : 577 - 584
  • [2] Li Jian Jun,Liu Hui Hui,Li Sha.Landscape of cardiometabolic risk factors in Chinese population: a narrative review[J].Cardiovascular Diabetology,2022
  • [3] Li Sha,Liu Hui-Hui,Guo Yuan-Lin,Zhu Cheng-Gang,Wu Na-Qiong,Xu Rui-Xia,Dong Qian,Li Jian-Jun.Improvement of evaluation in Chinese patients with atherosclerotic cardiovascular disease using the very-high-risk refinement: a population-based study[J].The Lancet Regional Health - Western Pacific,2021
  • [4] A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)
    Cao, Ye-Xuan
    Sun, Di
    Liu, Hui-Hui
    Jin, Jing-Lu
    Li, Sha
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Zhu, Cheng-Gang
    Gao, Ying
    Dong, Qiu-Ting
    Liu, Geng
    Dong, Qian
    Li, Jian-Jun
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (04) : 547 - 553
  • [5] Grundy Scott M,Stone Neil J,Bailey Alison L,Beam Craig,Birtcher Kim K,Blumenthal Roger S,Braun Lynne T,de Ferranti Sarah,Faiella-Tommasino Joseph,Forman Daniel E,Goldberg Ronald,Heidenreich Paul A,Hlatky Mark A,Jones Daniel W,Lloyd-Jones Donald,Lopez-Pajares Nuria,Ndumele Chiadi E,Orringer Carl E,Peralta Carmen A,Saseen Joseph J,Smith Sidney C,Sperling Laurence,Virani Salim S,Yeboah Joseph.2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholester
  • [6] Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease
    Cao, Ye-Xuan
    Wu, Na-Qiong
    Sun, Di
    Liu, Hui-Hui
    Jin, Jing-Lu
    Li, Sha
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Gao, Ying
    Dong, Qiu-Ting
    Liu, Geng
    Dong, Qian
    Li, Jian-Jun
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [7] Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)
    Li, Jian-Jun
    Lu, Zong-Liang
    Kou, Wen-Rong
    Chen, Zuo
    Wu, Yang-Feng
    Yu, Xue-Hai
    Zhao, Yu-Cheng
    [J]. ANNALS OF MEDICINE, 2010, 42 (03) : 231 - 240
  • [8] Zongliang Lu,Wenrong Kou,Baomin Du,Yangfeng Wu,Shuiping Zhao,Osvaldo A. Brusco,John M. Morgan,David M. Capuzzi.Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction[J].The American Journal of Cardiology,2008
1